期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈癌的免疫治疗进展

Development in immuntherapy for cervical cancer
下载PDF
导出
摘要 随着免疫学与分子生物学的发展 ,宫颈癌的免疫治疗研究也迅速进展 ,免疫治疗从多个方面进行 ,包括人乳头瘤病毒疫苗 ,树突状细胞免疫治疗 ,表面CD的单克隆抗体治疗等 。 With the development of immunology and molecular biology, the research on immunotherapy for cervical cancer also has progressed rapidly. The immunotherapy includes inoculations of human papillomavirus(HPV)and dendritic cell vaccine, monoclonal antibody of surface CD and so on. The article reviewed all above.
作者 吴砂 张昌菊
机构地区 三峡大学医学院免疫学教研室
出处 《国外医学（妇幼保健分册）》 2003年第6期404-405,419,共3页 Foreign Medical Sciences (Section of Maternal and Child Health)
关键词 宫颈癌 免疫治疗 疫苗 cervical cancer immunotherapy vaccine
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1[1]Borysiewicz L K, Fiander A, Nimadko M. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6and E7[J]. Lancet,1996,347(7) :1523 - 1527.
  • 2[2]Ronco L V, Karpova A Y, Vidal M. Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity[J]. Genes Dev,1998,12(13) :2061 - 2072.
  • 3[3]Gao Q, Srinivasan S, Boyer S N. The E6 oncoproteins of highrisk papillomaviruses bind to a novel putative GAP protein,E6TP1, and target it for degradation[J]. Mol Cell Biol, 1999,19(1) :733- 744.
  • 4[4]Burkhart B A, Alcorta D A, Chiao C, et al. Two posttranscriptional pathways that regulate p21 (Cip1/Waf1/Sdi1) are identified by HPV16-E6 interaction and correlate with life span and cellular senescence[J]. Exp Cell Res, 1999,247( 1 ): 168175.
  • 5[5]Harro C D, Pang Y Y, Roden R B, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16L1 virus-like particle vaccine[J]. J Natl Cancer Inst, 2001,93(4) :252 - 253.
  • 6[6]Bourgault V I, Beneton N, Bony C, et al. Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif[J]. Eur J Immunol,2000,30(8) :2281 - 2289.
  • 7[7]Muderspach L, Wilczynski S, Roman L, et al. A phase Ⅰ trail of a human papillomavirus(HPV) peptide vaccine for women with high-grade vervical and vulvar intraepithelial neoplasia who are HPV 16 positive[J]. Clin Cancer Res,2000,6(9) :3406- 3416.
  • 8[8]Boursnell M E, Rutherford E, Hickling J K, et al. Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer[J]. Vaccine, 1996,14(16): 1485 - 1494.
  • 9[9]Jabbar I A, Fernando G J, Saunders N, et al. Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 protein[J]. Vaccine,2000,18(22): 2444 - 2453.
  • 10[10]Smahel M, Sobotkova E, Vonka V, et al. DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7oncogenes and the activated ras oncogene [ J ]. Oncol Rep,1999,6(1) :211 - 215.
国外医学（妇幼保健分册）
2003年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部